Roche to acquire liver drug developer 89bio for up to $3.5 billion

89bio

18/09/2025 06:16

FRANKFURT, Sept 18 (Reuters) - Roche ROG.S said on Thursday it agreed to acquire U.S. biotech firm 89bio 
Recent news on 89bio
See all news
Swiss stocks - Factors to watch on October 2
02/10/2025 05:49
Brief: Roche Says Co Commences Tender Offer For All Shares Of 89Bio
01/10/2025 21:31
Deals of the day-Mergers and acquisitions
18/09/2025 21:09
Deals of the day-Mergers and acquisitions
18/09/2025 14:38
Deals of the day-Mergers and acquisitions
18/09/2025 10:57